Immuneering Corporation
IMRX
$3.93
-$0.11-2.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.24% | 22.62% | -3.68% | 4.07% | 16.65% |
| Total Depreciation and Amortization | 6.61% | -3.48% | -6.10% | -0.86% | -0.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.88% | 1.96% | -4.14% | -9.32% | 1.13% |
| Change in Net Operating Assets | -7,830.02% | -93.92% | -58.67% | 464.08% | -153.35% |
| Cash from Operations | -87.32% | 17.84% | -26.80% | 32.91% | 2.96% |
| Capital Expenditure | 35.51% | -1,597.26% | -247.62% | 76.40% | 5.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.90% | -- | -- | -- | -- |
| Cash from Investing | 28.91% | -1,215,241.10% | -247.62% | 76.40% | -100.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -57.93% | -99.80% | 10,298,328.57% | -99.98% | 13,710.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 74.39% | -4,704.53% | -- | -- |
| Cash from Financing | 150.57% | -100.17% | 343,958.23% | -100.45% | 33,784.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.79% | -149.16% | 2,215.70% | -3,308.67% | 96.92% |